about
Prion diseases: immunotargets and therapyImmunotherapy for tuberculosis: future prospectsCurrent perspectives on the immunopathogenesis of systemic sclerosisCurrent and emerging treatment options in the management of lupusRole of romiplostim in splenectomized and nonsplenectomized patients with immune thrombocytopeniaMetastatic renal cell carcinoma: update on epidemiology, genetics, and therapeutic modalitiesThe role of adipokines in chronic inflammationAntigen-based immunotherapy for autoimmune disease: current statusTherapeutic vaccines in non-small cell lung cancerThe role of regulatory T cells in cancer immunologyCD28 co-stimulation in T-cell homeostasis: a recent perspectiveCurrent perspectives on natural killer cell education and tolerance: emerging roles for inhibitory receptorsB cell receptor pathway in chronic lymphocytic leukemia: specific role of CC-292Antigen-based immunotherapy for the treatment of acute lymphoblastic leukemia: the emerging role of blinatumomabUpdate on the challenges and recent advances in cancer immunotherapyEmerging roles for HMGB1 protein in immunity, inflammation, and cancerHarnessing immunosurveillance: current developments and future directions in cancer immunotherapyAnti-ghrelin antibodies in appetite suppression: recent advances in obesity pharmacotherapyEmerging role of Natural killer cells in oncolytic virotherapyToll-like receptors in the pathogenesis of autoimmune diseases: recent and emerging translational developmentsInsights into the pathogenesis of Langerhans cell histiocytosis: the development of targeted therapiesTherapeutic cancer vaccines and combination immunotherapies involving vaccinationTargeting myeloid-derived suppressor cells augments antitumor activity against lung cancer.Targeting innate immunity to downmodulate adaptive immunity and reverse type 1 diabetes.CD8+ memory T-cell inflation renders compromised CD4+ T-cell-dependent CD8+ T-cell immunity via naïve T-cell anergy.Immunologic special forces: anti-pathogen cytotoxic T-lymphocyte immunotherapy following hematopoietic stem cell transplantation.Interleukin-17 and type 17 helper T cells in cancer management and research.Emerging options for the treatment of melanoma - focus on ipilimumab.Clinical potential of apremilast in the treatment of psoriatic arthritisHairy cell leukemia - immunotargets and therapiesNanocarrier-based immunotherapy in cancer management and research.The hygiene hypothesis: current perspectives and future therapiesPlace in therapy of rituximab in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis.Update on use of aldesleukin for treatment of high-risk metastatic melanoma.Identification, characterization, and synthesis of peptide epitopes and a recombinant six-epitope protein for Trichomonas vaginalis serodiagnosisImmunotherapy in the management of melanoma: current status.The association between Lambert-Eaton myasthenic syndrome and small cell lung carcinomaCancer as an immune-mediated disease.T-cell activation is enhanced by targeting IL-10 cytokine production in toll-like receptor-stimulated macrophages.Anti-amyloid beta to tau - based immunization: Developments in immunotherapy for Alzheimer disease.
P1433
Q26741258-B4EDD2A2-CD29-46CF-A7E2-33CD0F682AE2Q26741261-D7546F6F-CBF7-492B-9F74-1F70FE3B3A19Q26741264-443CEAA6-E60B-4007-8094-9CB2C4584768Q26741266-34B25EC6-7305-4205-BF20-9774AE624CD9Q26741269-C92B1A72-EAC3-4714-B0A4-939EB1539CBCQ26852437-87F4CC79-BBEC-487C-9F16-0F10A5CF7A76Q26852901-31EBAC14-6459-4837-B61F-F011F3FE2C65Q26852915-FF73EA68-9DAD-471C-BFC0-770683DA6BEEQ26864896-BD7A5971-993C-4A27-BCEA-E68FDFD8B737Q27006663-EB254DB7-3453-476B-8AF9-E909D86D56FEQ27007031-929988F9-F2B4-48DE-8FD3-1870F26D8D4CQ27009135-DEB21102-1991-45E0-B445-DADEBAD0B44FQ27009550-3F913288-B679-42B1-916C-71838CC0E205Q27013710-20D97698-D9FC-40E6-860A-AABA9BED9864Q27014693-F3B460EF-1BBC-4C60-9263-7FD65F7AF828Q27015835-BE34FD86-FD50-4CD8-B091-57E8A6BA5567Q27021570-6D27FDB3-AC21-48D5-ABF9-E3B60F79DCA8Q27023771-E6A3AAC6-64D9-401D-8318-0C7CFBD61C82Q27025330-6E64CF3C-01A4-45B9-93D7-20D455193505Q28067211-4E33F046-4421-4446-A034-3AA01D5891E7Q28071258-29FBC4BA-8647-4AC0-80F9-DDC0E0CAA127Q28397609-59F90FDA-9A42-4DD4-974E-AFD05AD18BB0Q30413623-FD467379-4388-49EF-BEAD-AE5633ABAC15Q33739020-5DDCC98D-2E93-4C02-91AC-76F13E11E062Q33820931-3F16AC53-8238-4E7C-A967-8B0B7B9B7B1DQ36956443-7B3D5833-D739-4A1C-A08E-26C0A83D499CQ37031654-0C9D3010-1339-4AA5-88CB-BE3B59C52116Q37031656-5E5F361A-AC06-4342-9E53-B199B973FCE2Q37031662-071DC648-D74E-4F0A-BBA0-5D3A4AEE7EDCQ37031666-0D3F4A03-9C81-4EF9-B97C-FB1268BFE505Q37031671-1BA15A2F-5403-4EEB-B32D-E85D6EC4D5DCQ37031687-46A6D203-BF15-4DFF-835F-008C604B9C92Q37031689-24BBEC9B-7D75-4049-8CE0-4468F990E3BCQ37031696-4BD85B94-F769-4336-9C60-7B53A158E9DCQ37054953-EF6D1C2C-4678-4697-A605-1EC60517F6D1Q37054958-37EABE0F-0C0B-4948-9216-B277AB119E5BQ37054967-90E18CDA-B728-4287-97AA-D4B13815703DQ37068312-D7218151-73A9-4F81-AC61-3D8F979C0408Q37068321-A266307D-D1CC-473C-B767-0A09DB162152Q38219981-969173FC-8DDD-4839-A7D3-A5C27CBCD66B
P1433
description
journal
@en
revista científica
@es
wetenschappelijk tijdschrift van Dove Medical Press
@nl
wissenschaftliche Fachzeitschrift
@de
name
ImmunoTargets and therapy
@ast
ImmunoTargets and therapy
@en
ImmunoTargets and therapy
@es
ImmunoTargets and therapy
@nl
type
label
ImmunoTargets and therapy
@ast
ImmunoTargets and therapy
@en
ImmunoTargets and therapy
@es
ImmunoTargets and therapy
@nl
altLabel
ImmunoTargets and Therapy
@en
Immunotargets Ther
@en
prefLabel
ImmunoTargets and therapy
@ast
ImmunoTargets and therapy
@en
ImmunoTargets and therapy
@es
ImmunoTargets and therapy
@nl
P31
P3181
P1055
P1156
21100853961
P1476
ImmunoTargets and therapy
@en